Franseen Labar

1. Tlesti linja ta 'produzzjoni, aktar minn 12-il sena ta' inġiniera tekniċi b'esperjenza u -ħaddiema mħarrġa tajjeb.
2. Il-prodotti kollha huma manifatturati u mibgħuta f'konformità stretta mal-istandards ISO9001:2015.
3. Żid ir-rata ta 'passaġġ għal 98 fil-mija fl-ogħla, filwaqt li tqassar il-ħin tal-produzzjoni b'madwar ġimgħa biex tipprovdi lill-klijenti l-aktar prodotti u servizzi effiċjenti.
4. Il-bejjiegħa tagħna huma fluwenti fl-Ingliż miktub u mitkellem, u l-inġiniera tagħna jikkwotaw malajr fi żmien 6 sigħat.
5. Twassil veloċi u f'waqtu, servizz veloċi u professjonali.
6. Il-klijenti jistgħu jużaw pjattaformi ta 'ħlas onlajn bħal PAYPAL biex iħallsu miżata żgħira tal-kampjun biex iqassar il-ħin tal-produzzjoni tal-kampjun.
7. Għandna kooperazzjoni kummerċjali tajba ma 'klijenti differenti minn pajjiżi differenti.

Ibgħat l-inkjesta

Deskrizzjoni

Speċifikazzjoni tal-Prodott

Isem tal-prodott	Labar Franseen
materjal	Stainless steel, eċċ.
Daqs tal-labra	12G, 14G, 16G, 18G, 19G, 20G, 21G, 22G, 23G, 25G, 26G, 30G, 31G, 32G
Proprjetajiet	Strument tat-titqib tal-injezzjoni
Karatteristika tad-dwana	Skont it-Tpinġija 2D/3D tiegħek jew il-kampjun ipprovdut
Pakkett	Standard carton or according to customer's requirement
Ċertifikazzjoni	ISO9001:2015, SGS

Uri tal-Prodott

In this study, in order to prove true histological tissue procurement, we used specialised imaging software to quantify individual tissue components. Our observations proved that the study hypothesis was correct: the Franseen biopsy needle yielded high-quality histology samples significantly more often than the standard FNA needle. Histological architecture was retained, and the total tissue and tumour yield from the FNB needles were 20 and 7 times greater, respectively, than that procured using FNA needles from the same lesion. Furthermore, desmoplastic fibrosis was seen in 85 percent of FNB samples compared with only 33 percent in the FNA cohort. Desmoplasia is an expected cellular reaction to a neoplastic process but is difficult to procure using standard bevel FNA needles as it requires 'coring' of the tissue. This is particularly relevant in clinical trials because patients with pancreatic cancer with activated stroma tend to have a poor prognosis and are less likely to benefit from neoadjuvant therapy. Two of the 10 samples in this study tested positive for K-ras G12D mutation, which is an independent prognostic marker for advanced ductal adenocarcinoma with poor response to gemcitabine-based chemotherapeutic regimens. Chromium Endoscopic Biopsy Needle